Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy

Published:2019-05-27 Issue:1 Volume:17 Page:
ISSN:1477-7819
Container-title:World Journal of Surgical Oncology
language:en
Short-container-title:World J Surg Onc

Author:

Depypere Lieven,Thomas Melissa,Moons Johnny,Coosemans Willy,Lerut Toni,Prenen Hans,Haustermans Karin,Van Veer Hans,Nafteux Philippe

Funder

Clinical research fund, university hospitals Leuven

Kom op tegen Kanker

Stichting Tegen Kanker

Fonds Wetenschappelijk Onderzoek

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1186/s12957-019-1630-8.pdf

Reference27 articles.

1. Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681–92. 2011/06/21. https://doi.org/10.1016/s1470-2045(11)70142-5 .

2. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998;339:1979–84. 1998/12/31. https://doi.org/10.1056/nejm199812313392704 .

3. Kelsen DP, Winter KA, Gunderson LL, et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol. 2007;25:3719–25. 2007/08/21. https://doi.org/10.1200/jco.2006.10.4760 .

4. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359:1727–33. 2002/06/07. https://doi.org/10.1016/s0140-6736(02)08651-8 .

5. Allum WH, Stenning SP, Bancewicz J, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27:5062–7. 2009/09/23. https://doi.org/10.1200/jco.2009.22.2083 .

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights from explainable AI in oesophageal cancer team decisions;Computers in Biology and Medicine;2024-09

2. Definitive Chemoradiotherapy versus Trimodality Therapy for Locally Advanced Esophageal Adenocarcinoma: A Multi-Institutional Retrospective Cohort Study;Cancers;2024-08-15

3. Practice pattern and risk of not receiving planned surgery after neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma;European Journal of Cardio-Thoracic Surgery;2024-06-24

4. Comparison of therapeutic outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A prospective observational cohort study;Journal of the Formosan Medical Association;2024-01

5. Endoscopic Palliative Therapies for Esophageal Cancer;Gastrointestinal Endoscopy Clinics of North America;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3